Clontech Gains Access to Smart-seq2 Single-Cell RNA-Seq Technology

March 24, 2015 Leave a comment 6,333 Views

MOUNTAIN VIEW, Calif., March 23, 2015 /PRNewswire/ — Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced that it has entered into an exclusive agreement with Ludwig Cancer Research for rights to the Smart-seq2 method for single-cell RNA-seq, ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Ludwig Cancer Research

Clontech Gains Access to Smart-seq2 Single-Cell RNA-Seq Technology

Dual RNA-Seq analysis of SARS-CoV-2 correlates specific human transcriptional response pathways directly to viral expression

ICRNASA 2022 – International Conference on RNA Sequencing and Analysis

New data suggest he percepta GSC RNA sequencing-based risk-stratification test can help accelerate timely treatment for patients with early-stage lung cancer

Quick determination of RNA-Seq strandedness

Benchmarking of a Bayesian single cell RNAseq differential gene expression test for dose–response study designs

Massively parallel direct RNA sequencing enables scientists to build ‘valves’ in DNA to shape biological information flows

Featured RNA-Seq Job – Research Associate/Senior Research Associate (Single Cell RNA Sequencing Library Preparation)